Top Ten Equity Holdings and Exposures

RNS Number : 4920Q
Polar Capital Global Health Tst PLC
06 June 2018
 

6th June 2018

 

Polar Capital Global Healthcare Trust plc (the "Company")

 

Top Ten Equity Holdings and Sector and Geographic Exposure as at 31st May 2018 and full Portfolio listing as at 30th April 2018 available from company's website

 

Polar Capital Global Healthcare Trust plc is pleased to announce that as at 31st May 2018 the top ten equity holdings and the sector and geographic breakdown were as follows:

 

Top 10 Holdings         

%

UnitedHealth Group

4.6%

Novartis

4.4%

Abbott Laboratories

4.2%

Becton Dickinson

4.0%

Eli Lilly & Co

3.9%

Danaher

3.8%

AstraZeneca

3.7%

HCA Holdings

3.4%

Fresenius Medical Care AG & Co

3.3%

Humana Inc

3.3%

Total

38.6%

 

 

 

Sector Exposure

%

Healthcare Equipment

26.4%

Biotechnology

19.5%

Pharmaceuticals

18.0%

Managed Healthcare

13.6%

Life Sciences Tools & Services

10.9%

Healthcare Facilities

3.4%

Healthcare Services

3.3%

Healthcare Technology

2.0%

Healthcare Supplies

1.6%

Education Services

0.5%

Cash

0.7%

Total

100.0%

 

 

 

 

Geographic Exposure

%

United States

70.7%

United Kingdom

11.1%

Japan

4.7%

Switzerland

3.9%

Germany

3.3%

Denmark

2.5%

Ireland

1.7%

Italy

0.7%

Sweden

0.5%

Norway

0.2%

Cash

0.7%

Total

100.0%

 

 

Gearing Ratio as calculated in accordance with the guidelines of the Association of Investment Companies, was 11.6%. Gearing is made up of structural debt provided by the subsidiary company PCGH ZDP plc, through the issue of zero dividend preference shares.

 

 

The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.co.uk

 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCFMGGVLVGGRZG
UK 100

Latest directors dealings